University of Cambridge
Urinary markers of brain lesions identified
Published in Telemedicine Business Week, August 18th, 2004
"Multiple sclerosis is a major cause of non-traumatic neurological disability," scientists in England explained. "The identification of markers that differentiate disease progression is critical to effective therapy."
In a study conducted by J.L. Griffin and colleagues at the University of Cambridge, a "combination of NMR spectroscopic metabolic profiling of urine and statistical pattern recognition was used to detect focal inflammatory central nervous system (CNS) lesions induced by microinjection of a replication-deficient recombinant adenovirus expressing TNF-alpha or IL1-beta cDNA into...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Business Week
More Articles from Telemedicine Business Week
- Axya Medical, Inc.
Device firm appoints D. Ronald Yagoda to board of directors - Bristol-Myers Squibb Company
Pharmaceutical firm reports earnings of $0.27 per share - OAO HealthCare Solutions, Inc.
Information technology company adds document imaging capability - TechniScan, Inc.
Stephen Blum joins ultrasound company's board - TriPath Imaging, Inc.
New molecular diagnostic tests released for external research - Aalborg Hospital
3-D stomach geography characterized with ultrasonography - More from this issue of Telemedicine Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
